{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:47:03Z","timestamp":1782845223053,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myxofibrosarcoma (MFS) is a rare, aggressive soft tissue sarcoma primarily affecting older adults. Despite curative-intent surgery and multimodal therapy, outcomes remain variable. Acute kidney injury (AKI) and sarcopenia are known complications in oncologic care, but their incidence and impact in MFS patients remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the incidence and consequences of AKI in adult MFS patients undergoing curative-intent surgery, and its association with survival, CT-based sarcopenia progression, and postoperative morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-center study, 49 adults with high-grade, N0M0 MFS who underwent curative-intent resection with or without multimodal therapy were included. AKI was defined as a\u2009\u2265\u20090.3\u00a0mg\/dL increase in serum creatinine. Sarcopenia and adipose tissue loss were assessed via serial CT morphometry scans at the L3 lumbar level. Associations between AKI and clinical outcomes (survival, function, length of hospital stay, surgical site infection) were evaluated using regression and survival analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      AKI occurred in 38.8% of patients and independently predicted decreased overall survival (HR 6.73;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0005). AKI was associated with accelerated loss of muscle tissue and visceral fat (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), functional decline (ECOG,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0078), longer hospitalization (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and increased wound infections (52.6% vs. 10.0%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first study to identify AKI as an independent predictor of mortality and sarcopenia in surgically treated MFS patients. CT morphometry may aid in early risk stratification, while renal monitoring offers a potential target for improving outcomes through nephroprotective strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-025-04145-x","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:37:13Z","timestamp":1764891433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute kidney injury predicts mortality, sarcopenia and postoperative morbidity in myxofibrosarcoma patients undergoing surgical resection"],"prefix":"10.1186","volume":"23","author":[{"given":"Julian","family":"Kylies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Kylies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana K.","family":"Striefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dupr\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Priemel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"4145_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.soc.2016.05.008","volume":"25","author":"CL Roland","year":"2016","unstructured":"Roland CL, Wang W-L, Lazar AJ, Torres KE, Myxofibrosarcoma. Surg Oncol Clin N Am. 2016;25:775\u201388.","journal-title":"Surg Oncol Clin N Am"},{"key":"4145_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.soc.2022.03.006","volume":"31","author":"AM Crago","year":"2022","unstructured":"Crago AM, Cardona K, Kose\u0142a-Paterczyk H, Rutkowski P. Management of Myxofibrosarcoma and undifferentiated pleomorphic sarcoma. Surg Oncol Clin N Am. 2022;31:419\u201330.","journal-title":"Surg Oncol Clin N Am"},{"key":"4145_CR3","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/diagnostics13193022","volume":"13","author":"J Nishio","year":"2023","unstructured":"Nishio J, Nakayama S. Biology and management of High-Grade myxofibrosarcoma: state of the Art and future perspectives. Diagnostics (Basel). 2023;13:3022.","journal-title":"Diagnostics (Basel)"},{"key":"4145_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000507334","volume":"43","author":"A Sambri","year":"2020","unstructured":"Sambri A, De Paolis M, Spinnato P, Donati DM, Bianchi G. The biology of myxofibrosarcoma: state of the Art and future perspectives. Oncol Res Treat. 2020;43:314\u201322.","journal-title":"Oncol Res Treat"},{"key":"4145_CR5","doi-asserted-by":"publisher","first-page":"175883592210939","DOI":"10.1177\/17588359221093973","volume":"14","author":"S Vanni","year":"2022","unstructured":"Vanni S, et al. Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives. Ther Adv Med Oncol. 2022;14:17588359221093973.","journal-title":"Ther Adv Med Oncol"},{"key":"4145_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/j.ackd.2022.04.001","volume":"29","author":"W Zafar","year":"2022","unstructured":"Zafar W, Kalra K, Ortiz-Melo DI. Oncosurgery-Related acute kidney injury. Adv Chronic Kidney Dis. 2022;29:161\u2013e1701.","journal-title":"Adv Chronic Kidney Dis"},{"key":"4145_CR7","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1159\/000540908","volume":"49","author":"M Floris","year":"2024","unstructured":"Floris M, et al. Acute kidney disease in oncology: A new concept to enhance the Understanding of the impact of kidney injury in patients with cancer. Kidney Blood Press Res. 2024;49:745\u201352.","journal-title":"Kidney Blood Press Res"},{"key":"4145_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12029-025-01169-0","volume":"56","author":"AE Abdulgalil","year":"2025","unstructured":"Abdulgalil AE, et al. Prevalence and risk factors of acute kidney injury after colorectal cancer surgery. J Gastrointest Canc. 2025;56:45.","journal-title":"J Gastrointest Canc"},{"key":"4145_CR9","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/ckj\/sfab292","volume":"15","author":"P Braet","year":"2021","unstructured":"Braet P, Sart\u00f2 GVR, Pirovano M, Sprangers B, Cosmai L. Treatment of acute kidney injury in cancer patients. Clin Kidney J. 2021;15:873\u201384.","journal-title":"Clin Kidney J"},{"key":"4145_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/nu13030761","volume":"13","author":"D Meza-Valderrama","year":"2021","unstructured":"Meza-Valderrama D, et al. Sarcopenia, Malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;13:761.","journal-title":"Nutrients"},{"key":"4145_CR11","doi-asserted-by":"crossref","unstructured":"Bossi P, Delrio P, Mascheroni A, Zanetti M. The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients. 2021;13:1980.","DOI":"10.3390\/nu13061980"},{"key":"4145_CR12","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1200\/JCO.21.00102","volume":"39","author":"GR Williams","year":"2021","unstructured":"Williams GR, Dunne RF, Giri S, Shachar SS, Caan B. J. Sarcopenia in the older adult with cancer. J Clin Oncol. 2021;39:2068\u201378.","journal-title":"J Clin Oncol"},{"key":"4145_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community\u2010dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7:290\u20138.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4145_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.ijo.0800875","volume":"23","author":"DB Allison","year":"1999","unstructured":"Allison DB, et al. Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int J Obes Relat Metab Disord. 1999;23:603\u201311.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4145_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/jso.24025","volume":"112","author":"S JOGLEKAR","year":"2015","unstructured":"JOGLEKAR S, NAU PN, MEZHIR JJ. The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature. J Surg Oncol. 2015;112:503\u20139.","journal-title":"J Surg Oncol"},{"key":"4145_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.avsg.2017.08.002","volume":"47","author":"MM Chowdhury","year":"2018","unstructured":"Chowdhury MM, et al. Morphometric assessment as a predictor of outcome in older vascular surgery patients. Ann Vasc Surg. 2018;47:90\u20137.","journal-title":"Ann Vasc Surg"},{"key":"4145_CR17","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00261-021-03294-3","volume":"47","author":"V Chianca","year":"2022","unstructured":"Chianca V, et al. Sarcopenia: imaging assessment and clinical application. Abdom Radiol. 2022;47:3205\u201316.","journal-title":"Abdom Radiol"},{"key":"4145_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00256-021-03951-0","volume":"51","author":"O Laur","year":"2022","unstructured":"Laur O, et al. Computed tomography-based body composition profile as a screening tool for geriatric frailty detection. Skeletal Radiol. 2022;51:1371\u201380.","journal-title":"Skeletal Radiol"},{"key":"4145_CR19","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/ajcn\/nqac273","volume":"116","author":"R Matsui","year":"2022","unstructured":"Matsui R, Watanabe J, Banno M, Inaki N, Fukunaga T. Association of visceral adipose tissue with postoperative outcome in upper Gastrointestinal cancer: a systematic review and meta-analysis. Am J Clin Nutr. 2022;116:1540\u201352.","journal-title":"Am J Clin Nutr"},{"key":"4145_CR20","doi-asserted-by":"publisher","first-page":"e70646","DOI":"10.1002\/cam4.70646","volume":"14","author":"PV Munch","year":"2025","unstructured":"Munch PV, et al. Risk of and mortality after acute kidney injury following cancer treatment: A cohort study. Cancer Med. 2025;14:e70646.","journal-title":"Cancer Med"},{"key":"4145_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1186\/s12885-023-11329-9","volume":"23","author":"K Andresen","year":"2023","unstructured":"Andresen K, et al. The risk of acute kidney injury in colorectal cancer survivors: an english population-based matched cohort study. BMC Cancer. 2023;23:839.","journal-title":"BMC Cancer"},{"key":"4145_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/ajh.25764","volume":"95","author":"R Chakraborty","year":"2020","unstructured":"Chakraborty R, Majhail NS. Treatment and disease-related complications in multiple myeloma: implications for survivorship. Am J Hematol. 2020;95:672\u201390.","journal-title":"Am J Hematol"},{"key":"4145_CR23","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.3390\/ijms22094618","volume":"22","author":"J Jagie\u0142a","year":"2021","unstructured":"Jagie\u0142a J, Bartnicki P, Rysz J. Nephrotoxicity as a complication of chemotherapy and immunotherapy in the treatment of colorectal cancer, melanoma and Non-Small cell lung cancer. Int J Mol Sci. 2021;22:4618.","journal-title":"Int J Mol Sci"},{"key":"4145_CR24","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1007\/s00432-022-04437-9","volume":"149","author":"K Liu","year":"2023","unstructured":"Liu K, et al. Acute kidney injury in advanced lung cancer patients treated with PD-1 inhibitors: a single center observational study. J Cancer Res Clin Oncol. 2023;149:5061\u201370.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4145_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.13425","volume":"15","author":"MP Duarte","year":"2024","unstructured":"Duarte MP, et al. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2024;15:501\u201312.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4145_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/medicina60050745","volume":"60","author":"SY Koh","year":"2024","unstructured":"Koh SY, et al. Sarcopenia, a risk predictor of postoperative acute kidney injury in elderly patients after hip fracture surgery: A retrospective analysis. Medicina. 2024;60:745.","journal-title":"Medicina"},{"key":"4145_CR27","doi-asserted-by":"crossref","unstructured":"Solagna F et al. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs. J Clin Invest. 2021;131.","DOI":"10.1172\/JCI135821"},{"key":"4145_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/jcsm.12705","volume":"12","author":"TJ Wilkinson","year":"2021","unstructured":"Wilkinson TJ, et al. Association of sarcopenia with mortality and end-stage renal disease in those with chronic kidney disease: a UK biobank study. J Cachexia Sarcopenia Muscle. 2021;12:586\u201398.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4145_CR29","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.3390\/nu13072212","volume":"13","author":"J-Y Bang","year":"2021","unstructured":"Bang J-Y, et al. Impact of sarcopenia on acute kidney injury after infrarenal abdominal aortic aneurysm surgery: A propensity matching analysis. Nutrients. 2021;13:2212.","journal-title":"Nutrients"},{"key":"4145_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","volume":"143","author":"JT RICH","year":"2010","unstructured":"RICH JT, et al. A PRACTICAL GUIDE TO UNDERSTANDING KAPLAN-MEIER CURVES. Otolaryngol Head Neck Surg. 2010;143:331\u20136.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"4145_CR31","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.3390\/ijms222111587","volume":"22","author":"D Constantin-Teodosiu","year":"2021","unstructured":"Constantin-Teodosiu D, Constantin D. Molecular mechanisms of muscle fatigue. Int J Mol Sci. 2021;22:11587.","journal-title":"Int J Mol Sci"},{"key":"4145_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505\u201322.","journal-title":"Nat Rev Cardiol"},{"key":"4145_CR33","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40620-020-00840-y","volume":"34","author":"A Sabatino","year":"2021","unstructured":"Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM. Sarcopenia in chronic kidney disease: what have we learned so far? J Nephrol. 2021;34:1347\u201372.","journal-title":"J Nephrol"},{"key":"4145_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejim.2023.12.002","volume":"123","author":"R Moreno-Gonz\u00e1lez","year":"2024","unstructured":"Moreno-Gonz\u00e1lez R, et al. Kidney function and other associated factors of sarcopenia in community-dwelling older adults: the SCOPE study. Eur J Intern Med. 2024;123:81\u201393.","journal-title":"Eur J Intern Med"},{"key":"4145_CR35","doi-asserted-by":"publisher","first-page":"11534","DOI":"10.1038\/s41598-018-29808-6","volume":"8","author":"Q He","year":"2018","unstructured":"He Q, Jiang J, Xie L, Zhang L, Yang M. A sarcopenia index based on serum creatinine and Cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people. Sci Rep. 2018;8:11534.","journal-title":"Sci Rep"},{"key":"4145_CR36","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/jcsm.13260","volume":"14","author":"M Okamura","year":"2023","unstructured":"Okamura M, et al. Kidney function in cachexia and sarcopenia: facts and numbers. J Cachexia Sarcopenia Muscle. 2023;14:1589\u201395.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4145_CR37","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1186\/s13063-022-06848-y","volume":"23","author":"K Lee","year":"2022","unstructured":"Lee K, et al. Telehealth exercise to improve physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic stem cell transplantation (TIPS): protocol of a randomized controlled trial. Trials. 2022;23:921.","journal-title":"Trials"},{"key":"4145_CR38","doi-asserted-by":"publisher","first-page":"e64905","DOI":"10.2196\/64905","volume":"13","author":"AJ Normann","year":"2024","unstructured":"Normann AJ, et al. Prehabilitation exercise training to target improved muscle strength in pretransplant patients diagnosed with multiple myeloma: protocol for a pilot randomized controlled trial. JMIR Res Protocols. 2024;13:e64905.","journal-title":"JMIR Res Protocols"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04145-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:34:41Z","timestamp":1765355681000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04145-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4145"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04145-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee of the Hamburg Medical Association, ID: 2025-300576-WF, consent to participate not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publish this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"451"}}